Glenmark Pharmaceuticals Ltd is currently trading at Rs 924.5, up by Rs 18.1 or 2% from its previous closing of Rs 906.4 on the BSE. The company posted that its net profit jumped 49% to Rs 556 crore in the quarter ended September 2016 as against Rs 372 crore during the previous quarter ended September 2015.
The sales of the company rose 30% to Rs 2,034 crore in the quarter ended September 2016 as against Rs 1,570 crore during the previous quarter ended September 2015.
The scrip opened at Rs 915 and has touched a high and low of Rs 938 and Rs 911 respectively. So far 356924 (NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs 25575.72 crore.
The BSE group 'A' stock of face value Rs 1 has touched a 52 week high of Rs 1009.5 on 28-Oct-2015 and a 52 week low of Rs 671.5 on 12-Feb-2016. Last one week high and low of the scrip stood at Rs 943.1 and Rs 900.15 respectively. The promoters holding in the company stood at 46.49 % while Institutions and Non-Institutions held 41.61 % and 11.91 % respectively. The stock is currently trading above its 50 DMA.